Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
The Expanding Role of CAR T Cells in Lymphoma and Leukemia - Episode 4
The Importance of Antigen Loss in R/R Disease
July 2, 2020
Stephen J. Schuster, MD, Abramson Cancer Center
,
Caron A. Jacobson, MD, Dana-Farber Cancer Institute
,
Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center
,
David Miklos, MD, Stanford University
,
Loretta J. Nastoupil, MD, MD Anderson Cancer Center
EP. 1: Rationale for Further Development of CAR T-Cell therapy
EP. 2: CAR T-Cell Therapy in Managing Various Lymphomas
EP. 3: R/R Large B-Cell Therapy in Managing Various Lymphomas
Now Viewing
EP. 4: The Importance of Antigen Loss in R/R Disease
EP. 5: Liso-cel Therapy in R/R Large B-Cell Lymphoma
EP. 6: LDH and ECOG Performance Tests
EP. 7: ZUMA-2 Trial Overview: Mantle Cell Lymphoma Impact
EP. 8: CAR T-Cell Therapy for Follicular Lymphoma
EP. 9: R/R NHL: Candidate Identification and Referrals
EP. 10: LBCL Therapy: The Right Therapy
EP. 11: CAR T Cells and Lymphoma Adverse Events
EP. 12: CAR T-Cell Therapy’s Future for Lymphoma
EP. 13: Allogenic CAR T-Cell Therapy in Lymphoma
EP. 14: Developing CAR T-Cell Trials
EP. 15: Ongoing Issues in CAR T-Cell Therapy and Lymphoma